Buchumschlag

Drug‐likeness evaluation and inhibitory mechanism of the emodin derivative on cardiac fibrosis based on metastasis‐associated protein 3

Fuente: Wiley Open Access

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Heng Liu, Runze Li, Zhixia Wang, Weina Han, Xiuxiu Sun, Xinxin Dong, Han Lou, Run Xu, Ange Hu, Denis Baranenko, Xue Bai, Dan Xiao, Weihong Lu
Format:	Artículo Open Access
Veröffentlicht:	Wiley 2025
Schlagworte:	British Journal of Pharmacology
Online-Zugang:	Acceder al recurso
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

Deep learning‐enhanced 3D imaging unveils semaglutide impact on cardiac fibrosis
von: Sheyla Barrado‐Ballestero, et al.
Veröffentlicht: (2025)

HIF‐1α and adaptor protein LIM and senescent cell antigen‐like domains protein 1 axis promotes tubulointerstitial fibrosis by interacting with vimentin in angiotensin II‐induced hypertension
von: Wei‐Jie Ni, et al.
Veröffentlicht: (2024)

An antisense oligonucleotide targeting the heat‐shock protein HSPB5 as an innovative therapeutic approach in pulmonary fibrosis
von: Pierre‐Marie Boutanquoi, et al.
Veröffentlicht: (2025)

Neurokinin‐1 receptor activation protects against cardiac fibrosis, inflammation and diastolic dysfunction in type 2 diabetic mice
von: Alexander Widiapradja, et al.
Veröffentlicht: (2026)

Daucosterol ameliorates acute inflammation and fibrosis following myocardial infarction via regulation of the ZBTB16 protein
von: Shihao Sheng, et al.
Veröffentlicht: (2025)

Correction to An antisense oligonucleotide targeting the heat‐shock protein HSPB5 as an innovative therapeutic approach in pulmonary fibrosis
Veröffentlicht: (2025)

Neutrophil extracellular traps drive tubulointerstitial fibrosis via the coiled‐coil domain‐containing protein 25 (CCDC25)–Yes‐associated protein 1 (YAP1) axis‐mediated autophagy regulation
von: Xinhui Hu, et al.
Veröffentlicht: (2026)

Kynurenic acid as a promising therapeutic agent in renal fibrosis: dual modulation of fibrosis and immune crosstalk
von: Sona Sykorova, et al.
Veröffentlicht: (2026)

tiRNA‐Gly‐GCC‐002 promotes epithelial‐mesenchymal transition and fibrosis in lupus nephritis via FKBP5‐mediated activation of Smad
von: Xueting Liu, et al.
Veröffentlicht: (2024)

Silencing the fibronectin gene (FN1 ) improves NaCl‐induced cardiac fibrosis via ferritinophagy‐mediated ferroptosis in a nuclear receptor coactivator 4 (NCOA4)‐dependent manner
von: Yawei Dai, et al.
Veröffentlicht: (2025)

Resveratrol, a novel inhibitor of fatty acid binding protein 5, inhibits cervical cancer metastasis by suppressing fatty acid transport into nucleus and downstream pathways
von: Xiao Chen, et al.
Veröffentlicht: (2024)

Biodiversity2Drugs—Renaissance of exploring nature‐derived peptides for GPCR ligand discovery
von: Christian W. Gruber, et al.
Veröffentlicht: (2025)

The cost‐effectiveness of cystic fibrosis transmembrane conductance regulator modulators: A systematic review of economic evaluations
von: Andrea Katrin Faour, et al.
Veröffentlicht: (2025)

The NADPH oxidase inhibitor Vas2870 prevents myocyte ferroptosis and improves cardiac remodelling and function in doxorubicin‐induced cardiomyopathy
von: Jing Wang, et al.
Veröffentlicht: (2026)

Sex‐related susceptibility to pulmonary fibrosis development in mice
von: Danilo D'Avino, et al.
Veröffentlicht: (2026)

JAK–STAT inhibitory effect of IN‐115314, a novel small molecule inhibitor, and pharmacokinetic/pharmacodynamic study in canine
von: Jae‐Hun Ahn, et al.
Veröffentlicht: (2025)

Disproportionality analysis of cardiac adverse events associated with lenvatinib using the Japanese Adverse Drug Event Report database
von: Yuko Kanbayashi, et al.
Veröffentlicht: (2024)

Difluorinated thromboxane A2 reveals crosstalk between platelet activatory and inhibitory pathways by targeting both the TP and IP receptors
von: Megan F. Allen, et al.
Veröffentlicht: (2024)

A comprehensive review of cancer‐induced cardiac wasting
von: Alessia Lena, et al.
Veröffentlicht: (2026)

Circular RNA regulatory role in pathological cardiac remodelling
von: Alessia Bibi, et al.
Veröffentlicht: (2024)

The role of free‐fatty acid receptors FFA1 and FFA4 in organ fibrosis
von: Priyanka F. Karmokar, et al.
Veröffentlicht: (2026)

Clu + transitional alveolar epithelial cells promote lung injury repair and fibrosis progression
von: Yuquan Wang, et al.
Veröffentlicht: (2026)

Pharmacological evaluation of non‐nucleotide purine derivatives as P2X7 antagonists for the treatment of neuroinflammation in traumatic brain injury
von: Inés Valencia, et al.
Veröffentlicht: (2025)

Genetic deficiency or pharmacological inhibition of cGAS–STING signalling suppresses kidney inflammation and fibrosis
von: Baihai Jiao, et al.
Veröffentlicht: (2025)

Correction to “AQX‐1125, small molecule SHIP1 activator inhibits bleomycin‐induced pulmonary fibrosis”
Veröffentlicht: (2024)

Diminished nuclear‐localized β‐adrenoceptor signalling activates YAP to promote kidney fibrosis in diabetic nephropathy
von: Wenjing Xiang, et al.
Veröffentlicht: (2024)

Anti‐chitinase‐3‐like 1 antibody attenuated atopic dermatitis‐like skin inflammation through inhibition of STAT3‐dependent CXCL8 expression
von: Ji Eun Yu, et al.
Veröffentlicht: (2024)

Targeting acetylated high mobility group box 1 protein (HMGB1) and toll‐like receptor (TLR4) interaction to alleviate hypertension and neuroinflammation in fructose‐fed rats
von: Yu‐Te Lin, et al.
Veröffentlicht: (2024)

Activation of autophagy mediated by PI3K/Akt/mTOR signalling cascade alleviates impaired adipose‐derived stem cell osteogenesis in a diabetic microenvironment
von: Fangzhi Lou, et al.
Veröffentlicht: (2025)

P2X7 receptor antagonism suppresses epileptiform‐like activity in an inflammation‐primed human iPSC‐derived neuron model of drug‐resistant epilepsy
von: Jaideep Kesavan, et al.
Veröffentlicht: (2025)

Beyond TGFβ inhibition: Chitosan oligosaccharide targets PGC‐1α‐mediated mitochondrial repair to combat pulmonary fibrosis
von: Huan He, et al.
Veröffentlicht: (2025)

Targeting IL‐11 to reduce fibrocyte circulation and lung accumulation in animal models of pulmonary hypertension‐associated lung fibrosis
von: Javier Milara, et al.
Veröffentlicht: (2024)

Hydnocarpin D‐induced microRNA‐145‐5p down‐regulates SERPINE1 and suppresses metastasis in ovarian cancer
von: Zhihui Zhu, et al.
Veröffentlicht: (2025)

TRPC6 suppresses liver fibrosis by inhibiting hepatic stellate cell activation via CaMK4‐CREB pathway
von: Shan Jiang, et al.
Veröffentlicht: (2025)

PDE4B inhibition by nerandomilast: Effects on lung fibrosis and transcriptome in fibrotic rats and on biomarkers in human lung epithelial cells
von: Dennis Reininger, et al.
Veröffentlicht: (2024)

Stabilisation of PRCP by deubiquitinase‐targeting chimera (DUBTAC) to replenish autophagy for ameliorating pathological cardiac hypertrophy
von: Fangchao Zhou, et al.
Veröffentlicht: (2025)

Exosomes from macrophages intervened by Jiedu Yangxin decoction mediated endothelial‐to‐mesenchymal transition to improve myocardial fibrosis after myocardial infarction
von: Lingwen Cui, et al.
Veröffentlicht: (2026)

Correction to ‘Stabilisation of PRCP by deubiquitinase‐targeting chimera (DUBTAC) to replenish autophagy for ameliorating pathological cardiac hypertrophy’
Veröffentlicht: (2025)

In silico , in vitro and ex vivo characterization of cystic fibrosis transmembrane conductance regulator pathogenic variants localized in the fourth intracellular loop and their rescue by modulators
von: Emanuela Pesce, et al.
Veröffentlicht: (2025)

The first in‐human study to evaluate the antiplatelet properties of the clopidogrel conjugate DT‐678 in acute coronary syndrome patients and healthy volunteers
von: Zhihao Liu, et al.
Veröffentlicht: (2024)